ArticleFrontiers in pediatrics2022

Risk Factors of Very Severe RSV Infections in a Multicenter Cohort of Very Preterm and Extreme Preterm Babies Receiving or Not Palivizumab.

Gwenaelle Mulot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.